Issue navigation
Volume 176, Issue 3, 1 March 2017
Editor's Choice
Editor's Choice
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Page i, https://doi.org/10.1111/bjd.15361
EDITORIALS
Identifying biomarkers in human psoriasis: revealed by a systems metabolomics approach
J. Yan
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 555–557, https://doi.org/10.1111/bjd.15249
Every dermatology consultation: think adherence
A.Y. Finlay
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 558–559, https://doi.org/10.1111/bjd.15250
Systems medicine and psoriasis
C.E.M. Griffiths
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 560–562, https://doi.org/10.1111/bjd.15334
COMMENTARIES
Quality of life instruments in psoriasis clinical trials
D. Kivelevitch and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Page 563, https://doi.org/10.1111/bjd.15102
Dimethyl fumarate finally coming of age
D.M.W. Balak
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 563–564, https://doi.org/10.1111/bjd.15330
Etanercept or infliximab for psoriasis? An independent randomized clinical trial
A.D. Burden
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Page 565, https://doi.org/10.1111/bjd.15160
Psoriasis and increased drug utilization: a true burden of psoriasis or potential surveillance bias of comorbidities?
Z.Z.N. Yiu
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 566–567, https://doi.org/10.1111/bjd.15018
Registries and biologics: disease populations matter
L. Puig
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 567–568, https://doi.org/10.1111/bjd.15134
Increasing prevalence but not incidence of psoriasis in the U.K.
A.E. Cust and D.F. Murrell
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 568–569, https://doi.org/10.1111/bjd.15331
Could maternal stress increase the risk of developing psoriasis in the offspring?
P. Gisondi
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 569–570, https://doi.org/10.1111/bjd.15329
Indoleamine 2,3‐dioxygenase in psoriasis: a defective mechanism
S. Trabanelli
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 570–572, https://doi.org/10.1111/bjd.15097
Interleukin‐17 blockade in generalized pustular psoriasis – new hope for severely ill patients
A. Reich
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 572–573, https://doi.org/10.1111/bjd.14987
Secukinumab shows reassuring low immunogenicity
A. Makrygeorgou
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 573–574, https://doi.org/10.1111/bjd.15332
Patient education and screening for psoriatic arthritis is key in the care of patients with psoriasis, whichever method is chosen
L.C. Coates
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 574–575, https://doi.org/10.1111/bjd.15333
Absolute Psoriasis Area and Severity Index: an additional evaluation for clinical practice
J. Zheng
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Page 576, https://doi.org/10.1111/bjd.15216
Reviews
SYSTEMATIC REVIEWS
A systematic review of the use of quality‐of‐life instruments in randomized controlled trials for psoriasis
F.M. Ali and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 577–593, https://doi.org/10.1111/bjd.14788
Short‐term efficacy and safety of new biological agents targeting the interleukin‐23–T helper 17 pathway for moderate‐to‐severe plaque psoriasis: a systematic review and network meta‐analysis
F. Gómez‐García and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 594–603, https://doi.org/10.1111/bjd.14814
REVIEW ARTICLE
Topical treatments for scalp psoriasis: summary of a Cochrane Systematic Review
J.G. Schlager and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 604–614, https://doi.org/10.1111/bjd.14811
Original articles
CLINICAL TRIALS
Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate‐to‐severe chronic plaque psoriasis: a randomized, double‐blind, Fumaderm®‐ and placebo‐controlled trial (BRIDGE)
U. Mrowietz and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 615–623, https://doi.org/10.1111/bjd.14947
A prospective randomized controlled trial comparing infliximab and etanercept in patients with moderate‐to‐severe chronic plaque‐type psoriasis: the Psoriasis Infliximab vs. Etanercept Comparison Evaluation (PIECE) study
A.C.Q. de Vries and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 624–633, https://doi.org/10.1111/bjd.14867
EPIDEMIOLOGY
Increased overall drug utilization in patients with psoriasis: a case–control study based on Dutch general practitioner data
E.A. Dowlatshahi and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 634–642, https://doi.org/10.1111/bjd.14754
Should tumour necrosis factor antagonist safety information be applied from patients with rheumatoid arthritis to psoriasis? Rates of serious adverse events in the prospective rheumatoid arthritis BIOBADASER and psoriasis BIOBADADERM cohorts
I. García‐Doval and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 643–649, https://doi.org/10.1111/bjd.14776
Incidence, prevalence and mortality of patients with psoriasis: a U.K. population‐based cohort study
D.A. Springate and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 650–658, https://doi.org/10.1111/bjd.15021
Prenatal exposure to maternal bereavement and offspring psoriasis: a Danish nationwide cohort study
X. Liu and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 659–666, https://doi.org/10.1111/bjd.15224
QUALITATIVE AND OUTCOMES RESEARCH
Nonadherence to psoriasis medication as an outcome of limited coping resources and conflicting goals: findings from a qualitative interview study with people with psoriasis
R.J. Thorneloe and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 667–676, https://doi.org/10.1111/bjd.15086
Motivational interviewing‐based training enhances clinicians’ skills and knowledge in psoriasis: findings from the Pso Well® study
A. Chisholm and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 677–686, https://doi.org/10.1111/bjd.14837
Predictors of perceived stigmatization in patients with psoriasis
S. van Beugen and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 687–694, https://doi.org/10.1111/bjd.14875
TRANSLATIONAL RESEARCH
Immune cells from patients with psoriasis are defective in inducing indoleamine 2,3‐dioxygenase expression in response to inflammatory stimuli
M. Llamas‐Velasco and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 695–704, https://doi.org/10.1111/bjd.14779
Reducing Flightless I expression decreases severity of psoriasis in an imiquimod‐induced murine model of psoriasiform dermatitis
H.T. Chong and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 705–712, https://doi.org/10.1111/bjd.14842
Exploration of candidate biomarkers for human psoriasis based on gas chromatography‐mass spectrometry serum metabolomics
H. Kang and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 713–722, https://doi.org/10.1111/bjd.15008
Ubiquitin‐specific peptidase 2 as a potential link between microRNA‐125b and psoriasis
T. Wei and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 723–731, https://doi.org/10.1111/bjd.14916
Increased global arterial and subcutaneous adipose tissue inflammation in patients with moderate‐to‐severe psoriasis
K.F. Hjuler and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 732–740, https://doi.org/10.1111/bjd.15149
MEDICAL DERMATOLOGY
Efficacy and safety of brodalumab in patients with generalized pustular psoriasis and psoriatic erythroderma: results from a 52‐week, open‐label study
K. Yamasaki and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 741–751, https://doi.org/10.1111/bjd.14702
Secukinumab, a fully human anti‐interleukin‐17A monoclonal antibody, exhibits minimal immunogenicity in patients with moderate‐to‐severe plaque psoriasis
K. Reich and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 752–758, https://doi.org/10.1111/bjd.14965
Long‐term adherence to topical psoriasis treatment can be abysmal: a 1‐year randomized intervention study using objective electronic adherence monitoring
H. Alinia and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 759–764, https://doi.org/10.1111/bjd.15085
Comparison of four validated psoriatic arthritis screening tools in diagnosing psoriatic arthritis in patients with psoriasis (COMPAQ Study)
S. Mishra and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 765–770, https://doi.org/10.1111/bjd.14929
PAEDIATRIC DERMATOLOGY
Validation of the Simplified Psoriasis Index in Dutch children and adolescents with plaque psoriasis
M.J. van Geel and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 771–776, https://doi.org/10.1111/bjd.15120
GENERAL DERMATOLOGY
Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete‐choice experiment
J.M. Gonzalez and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 777–785, https://doi.org/10.1111/bjd.14798
Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort
J. Zweegers and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 786–793, https://doi.org/10.1111/bjd.14888
PERSPECTIVES
Disease‐specific treatment registries for research: psoriasis as an exemplar
Z.Z.N. Yiu
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 794–796, https://doi.org/10.1111/bjd.15291
Correspondence
RESEARCH LETTERS
Possible paradoxical occurrence of inflammatory arthritis in patients with psoriasis treated with biologics: findings in the Biobadaderm cohort
D. Ruiz‐Genao and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 797–799, https://doi.org/10.1111/bjd.14690
Increase in coronary atherosclerosis severity and the prevalence of coronary artery mixed plaques in patients with psoriasis
R. Bissonnette and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 800–802, https://doi.org/10.1111/bjd.14797
Combination therapy of infliximab and ciclosporin in the treatment of recalcitrant psoriasis: a case series
C. Martinez‐Mera and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 803–805, https://doi.org/10.1111/bjd.15229
Safety, complications and patients’ acceptance of Mohs micrographic surgery under local anaesthesia: results from the U.K. MAPS (Mohs Acceptance and Patient Safety) Collaboration Group
W. Hussain and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 806–808, https://doi.org/10.1111/bjd.14843
Clinical evaluation of local hyperthermia at 44 °C for molluscum contagiosum: pilot study with 21 patients
Y.‐L. Gao and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 809–812, https://doi.org/10.1111/bjd.14849
Sebopsoriasis in patients with HIV: a case series of 20 patients
T.J. Tull and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 813–815, https://doi.org/10.1111/bjd.14874
Voriconazole exposure regulates distinct cell‐cycle and terminal differentiation pathways in primary human keratinocytes
M. Mansh and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 816–820, https://doi.org/10.1111/bjd.14838
Oral glycopyrrolate after the failure of oral oxybutynin in the treatment of primary hyperhidrosis
J. del Boz and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 821–823, https://doi.org/10.1111/bjd.14876
Paraneoplastic pemphigus with anti‐BP180 autoantibodies and Castleman disease
L. Maier and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 824–826, https://doi.org/10.1111/bjd.14877
Fatigue as a symptom in psoriasis and psoriatic arthritis: an observational study
A.M. Tobin and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 827–828, https://doi.org/10.1111/bjd.15258
LETTERS TO THE EDITOR
The cross‐talk between renal function, inflammation and psoriasis vulgaris
S. Coimbra and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 829–831, https://doi.org/10.1111/bjd.14913
Hydroxychloroquine prescribing and monitoring practices among Irish dermatologists and rheumatologists
E. Gilhooley and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 831–832, https://doi.org/10.1111/bjd.15192
Cutis laxa acquisita: novel insights into impaired elastic fibre regeneration
P. Gkogkolou and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 832–835, https://doi.org/10.1111/bjd.15196
Regarding ‘Frontal fibrosing alopecia: possible association with leave‐on facial skincare products and sunscreens; a questionnaire study’
A. Dhana and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages 836–837, https://doi.org/10.1111/bjd.15197
Dermatological content of U.K. undergraduate curricula: where are we now?
A. Yaakub and others
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Page 836, https://doi.org/10.1111/bjd.15206
News and Notices
News and Notices
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Page 837, https://doi.org/10.1111/bjd.15411
PLAIN LANGUAGE SUMMARIES
Plain language summaries
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages e23–e27, https://doi.org/10.1111/bjd.15351
Plain language summaries in Simplified Chinese
British Journal of Dermatology, Volume 176, Issue 3, 1 March 2017, Pages e28–e31, https://doi.org/10.1111/bjd.15383
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals